Member Info for chanlfc

is out, MM's need shares.

News should be incoming anytime between now and 13th. They will need to release it before presentation.

MMs playing games this morning, they know whats coming....

Only fools part from their shares when you so close to the game changing news

For whats its worth, if Japan study is good, Clevegen successful, you wont able to buy below the yrs high and thats close to £9.

Talk of £25 was a target and its probably the reason why Dr Jonathan Knowles bought 1/2 million pounds worth at 7x the SP price of today.

GLA

MM's are doing what they good at, making you sell your shares cheap ready to sell them back to you at a much higher level.

Dont be fooled by there games.

All Directors bought more in June after the disappointing results.

Not forgetting the £456,750 @ £7.25 late 2017.

Im happy to wait for Jap study results that will be discussed in detail on 13th and most likely announcement before this date.

Good entry for the run up to 13th and the rerate .

mop up those shares while you can IMO

An order is definitely being filled, Im expecting a TR1 and then game on.....

MM's wont able to keep this down for long and those buying and holding will the ones to benefit in the short term

it doesn't matter what the company has done in the past, it what its going to do tomorrow.

Let see what next update brings...

GLA

So what are you doing on here teabiscuit? you don't think good news around the corner and you not invested.

You certainly have an agenda.

"....Half year results are on 13 September 2018 and there will be an update across the business that day, including on the Japanese study..."

I expect news before then...

GLA

Or they could say "successful" and its bagging a few times just on that and sentiment changes for the better.

Risk/reward play.... I'm going for the latter .

GLA

Earlier buy gave us a little clue I think.

Optimistic we shall see that rerate coming

"Half year results are on 13 September 2018 and there will be an update across the business that day, including on the Japanese study."

So we will have news before so they can discuss I presume ?

https://www.sharesmagazine.co.uk/news/shares/faron-crashes-on-shocking-trial-failure

https://otp.tools.investis.com/clients/uk/faron/rns/regulatory-story.aspx?cid=2223&newsid=1007071

Dr Markku Jalkanen, CEO of Faron, said: "We are incredibly disappointed and surprised by these results. We need to further analyse the data in order to understand how this study differs from our previous positive results with ARDS patients, both in terms of Traumakine's efficacy, and in the unusually low mortality rate observed in the placebo arm. We look forward to the results of the Japanese study in Q3 2018 and will be considering how we can advance Traumakine in clinical development.

https://twitter.com/chanlfc/status/1032214866260635648

Not long to go now.

I think the Build will start now, I wouldn't want to be out of this share now being so close to news and with interim results and presentation and conference call on the 13th.

https://youtu.be/gv3XX3tz1ek

Another day closer, we should get the results before the 13th IMO.

I'm sure management will like to do the presentation with full details and whats to come in coming weeks/months after.

If you not buying now then best of luck on your entry.

It will blow, those results are pivotal and signs are it will be good. Rerate back over $8 and that's without the Clevegen news with human trials in Q4 2018.

GLA.

Pivotal Phase III ARDS trial study result I think will be with us very shortly.

Coupled with the first Clevegen human trial in Q4 2018 has the potential to meet previous target potential of £25.

That's a 25 bagger potential in short order.

GLA.